Discover how SB000 offers a safe alternative for cell rejuvenation without activating dangerous pluripotency pathways.

What if you could actually see where a drug travels in the body down to the cellular level. Find out how mass spectrometry ...

Explore GPCR-targeting therapies and their untapped potential in drug development, making up 30-35 percent of approved drugs.

Explore the collaboration between lab and data scientists to overcome communication challenges in life sciences.

Understand the challenges and impacts of the 3Rs on animal welfare in research with Dr. Liz Nunamaker's expert interview.

Learn about the innovative method to create aptamers that could revolutionise treatments for infectious diseases.

Explore the potential of protein design with the new deep learning approach from Chongqing University to enhance binding ...

Learn how radiopharmaceuticals are transforming nuclear medicine and cancer therapy through targeted diagnostics and ...

Learn how antibody to payload design is crucial for advancing ADC technology in oncology and beyond with expert insights.

Drug development has long been hindered by fragmented data and complex processes, but a new wave of AI is reshaping the landscape. By integrating genomic, clinical and molecular data, multimodal ...

Dr. Francisca Neethling from Eurofins Discovery explores the comprehensive process of ADC development, covering payload linker design, optimization, and the bioanalytical and functional ...